Just a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to step aside by the board following an investigation into suspected illegal activity by Chinese customs.

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET ...

Ying Huang, PhD, chief executive officer of Legend Biotech, explains that, with over 5,600 patients treated worldwide, the company is laying the groundwork for the broader adoption of CAR T-cell ...

And for all the emphasis on revenue and competitive strength, Zhang continues to make forays into early-stage biotech—sometimes with sizable positions. Manager Amy Zhang’s preference for high ...

1 Day LEGN 4.79% DJIA 0.32% S&P 500 0.09% Health Care/Life Sciences -0.79% ...

DOVER, Del., April 28, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company today reports confirmatory preclinical efficacy data for PORT-7 (TT-4 ...

LAS VEGAS, May 21, 2024--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company"), today announced a $7 million investment in MyMD Pharmaceuticals, Inc ...

Despite the... ByInvesting.com • Mar 25, 2025 LICN stock touches 52-week low at $4.5 amid sharp annual decline Legend Biotech Corporation (LICN) stock has plummeted to a 52-week low, trading at ...